Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligonucleotide therapeutics.

J S Cohen1

  • 1Department of Pharmacology, Georgetown University Medical School, Rockville, MD 20850.

Trends in Biotechnology
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Oligonucleotides can alter genetic processes in various organisms, including viruses. This suggests their potential as future biotechnologically derived therapeutics for diseases like cancer and AIDS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incremental risk of fragility fractures in aging men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability, neuromuscular and psychiatric symptoms.

Clinical genetics·2017
Same author

Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.

Clinical genetics·2017
Same author

Further evidence that de novo missense and truncating variants in ZBTB18 cause intellectual disability with variable features.

Clinical genetics·2016
Same author

Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.

Clinical genetics·2014
Same author

The role of trial tracking on rats' successive delayed matching-to-sample modality performance.

Behavioural processes·2014
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
Same journal

Acoustic cavitation-enhanced lymphatic trafficking of inhaled bacterial-sourced biohybrid vaccines for antitumor immunity.

Trends in biotechnology·2026
Same journal

Make uphill thermodynamics downhill in pathway design.

Trends in biotechnology·2026
See all related articles

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • Oligonucleotides are short nucleic acid sequences with diverse biological functions.
  • Recent research highlights their impact on the genetic machinery of various organisms.
  • Viruses represent a key area of investigation for oligonucleotide-based interventions.

Purpose of the Study:

  • To explore the potential of oligonucleotides as therapeutic agents.
  • To investigate the genetic effects of oligonucleotides on viruses and other organisms.
  • To identify biotechnologically derived compounds for disease treatment.

Main Methods:

  • Review of recent studies on oligonucleotide interactions with genetic material.
  • Analysis of oligonucleotide efficacy in modulating genetic processes.

Related Experiment Videos

  • Assessment of potential applications in biotechnology and medicine.

    • Main Results:

    • Oligonucleotides demonstrate the ability to influence genetic processes.
    • This influence extends to viral genetic mechanisms.
    • Evidence suggests broad applicability across different organisms.

    Conclusions:

    • Oligonucleotides hold significant promise as a source of novel therapeutics.
    • Biotechnological applications for treating cancer and AIDS are foreseeable.
    • Further research into oligonucleotide mechanisms can unlock new treatment strategies.